Manufacturer copay assistance · Tezspire (J2356) · AstraZeneca/Amgen
$0 · Maximum benefit $13,000/year drug + $1,200/year admin ($100/month) · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Tezspire — the program's cap applies against the patient share CareCost calculates.
Yes — Tezspire Together Co-Pay Program from AstraZeneca/Amgen. $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$0 Maximum benefit: $13,000/year drug + $1,200/year admin ($100/month). Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicaid, medicare, government.